Skip to content

China PEACE 5r-HF Study

China Patient-centered Evaluative Assessment of Cardiac Events (PEACE): Retrospective Study of Patients With Heart Failure (HF)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02877914
Enrollment
10000
Registered
2016-08-24
Start date
2016-09-30
Completion date
2018-04-30
Last updated
2017-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

heart failure, retrospective

Brief summary

This study will use a two-stage random sampling design to create a nationally representative sample of patients with heart failure (HF) in China. The investigators sought to describe the clinical profiles, to assess treatment patterns and in-hospital outcomes for HF, and to identify targets for care quality improvement.

Detailed description

This study will use a two-stage random sampling design to create a nationally representative sample in China, and randomly sample patients with HF as a primary diagnosis, and were admitted to hospital from January 1st, 2015 to December 31st, 2015. The sample size is estimated to be 10,000. The investigators will collect photocopies of the sampled medical records and centrally abstract detailed information, which included demographic characteristics, medical history, clinical features, diagnostic tests, in-hospital procedures, lab tests, treatments, and in-hospital outcomes. Data abstraction quality was monitored by random auditing of 5% of the medical records, with overall variable accuracy exceeding 98%. Analyses will examine patient characteristics, diagnostic testing patterns, in-hospital treatments, in-hospital outcomes, and variation in results across regions and hospitals. Practical guidelines, quality evaluative system, and risk model will be established based on the findings, to improve patient outcomes for HF in the future.

Interventions

OTHERObservational study

This is a non-interventional study, patients receive their usual treatment as determined by the physician.

Sponsors

China National Center for Cardiovascular Diseases
Lead SponsorOTHER_GOV

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with heart failure as the primary reason for hospitalization, including both new-onset HF or decompensation of chronic HF。 * Hospitalized during January 1st, 2015 to December 31st, 2015 * Aged 18 years or above

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
DeathDuration of hospitalization, an average of 10 days

Countries

China

Contacts

Primary ContactJing Li, MD, PhD
jing.li@fwoxford.org+86 (10) 6086 6077
Backup ContactYuan Yu, MD
yuan.yu@fwoxford.org+86 17801013954

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026